Rani Therapeutics Holdings (RANI) Enterprise Value Growth (1y) (2021 - 2026)
Rani Therapeutics Holdings (RANI) Enterprise Value Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Rani Therapeutics Holdings | 160.20 Mn | 167.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 79.80% |
| Dec 31, 2025 | -347.41% |
| Sep 30, 2025 | -409.06% |
| Jun 30, 2025 | -666.76% |
| Mar 31, 2025 | -4,870.77% |
| Dec 31, 2024 | -133.68% |
| Sep 30, 2024 | -113.19% |
| Jun 30, 2024 | -110.89% |
| Mar 31, 2024 | -97.81% |
| Dec 31, 2023 | 107.60% |
| Sep 30, 2023 | -28.50% |
| Jun 30, 2023 | -67.50% |
| Mar 31, 2023 | -79.25% |
| Dec 31, 2022 | -104.07% |
| Sep 30, 2022 | 134.80% |
| Jun 30, 2022 | 173.35% |
| Dec 31, 2021 | 40.74% |
| Jun 30, 2021 | -775.62% |